- Home
- Investors
- Annual general meeting
- Results of voting at AGMs
Results of voting at AGMs
Issued - Wednesday 21 May 2008, London - LSE AnnouncementVoting on the resolutions put to each AGM is on a poll rather than by a show of hands. The results of the poll are announced to the London Stock Exchange, via the Regulatory Information Service, as soon as practicable after the AGM. They are also published on this page.
Results of AGM
GlaxoSmithKline (GSK) announces that at today's Annual General
Meeting all resolutions, including
those electing
and re-electing Board members, were passed by shareholders.
The following table shows the votes cast for each resolution:
| Resolution | Total Votes For* | % | Total Votes Against | % | Total Votes Cast | Abstentions ** | |
|---|---|---|---|---|---|---|---|
| 1. | Adoption of Financial Statements | 3,749,614,298 |
95.18% |
189,859,453 |
4.82% |
3,939,473,751 |
9,410,864 |
| 2. | Approval of the Remuneration Report | 2,423,411,670 |
85.89% |
398,271,204 |
14.11% |
2,821,682,874 |
1,127,201,561 |
| 3. | Election of Mr Andrew Witty | 3,877,718,934 | 99.23% |
29,969,659 |
0.77% |
3,907,688,593 |
41,195,842 |
| 4. | Election of Mr Christopher Viehbacher | 3,849,501,839 |
99.49% |
19,772,868 |
0.51% |
3,869,274,707 |
79,609,728 |
| 5. | Election of Professor Sir Roy Anderson | 3,909,528,117 |
99.82% |
7,050,023 |
0.18% |
3,916,578,140 |
32,306,295 |
| 6. | Re-election of Sir Christopher Gent | 3,810,072,560 |
98.08% |
74,773,259 |
1.92% |
3,884,845,819 |
64,038,616 |
| 7. | Re-election of Sir Ian Prosser | 3,907,565,196 |
99.77% |
9,050,718 |
0.23% |
3,916,615,914 |
32,268,521 |
| 8. | Re-election of Dr Ronaldo Schmitz | 3,899,485,674 |
99.56% |
17,139,141 |
0.44% |
3,916,624,815 |
32,259,620 |
| 9. | Re-appointment of Auditors | 3,877,708,481 |
99.54% |
17,936,334 |
0.46% |
3,895,644,815 |
53,239,620 |
| 10. | Remuneration of Auditors | 3,913,134,400 |
99.69% |
12,121,289 |
0.31% |
3,925,255,689 |
23,628,746 |
| 11. | To authorise the company to make donations to Political Organisations & incur Political Expenditure | 3,764,947,848 |
97.09% |
112,911,635 |
2.91% |
3,877,859,483 |
71,024,952 |
| 12. | Authority to allot shares | 3,877,961,825 |
98.44% |
61,623,083 |
1.56% |
3,939,584,908 |
9,299,527 |
| 13. | Disapplication of pre-emption rights*** | 3,891,091,851 |
98.82% |
46,291,865 |
1.18% |
3,937,383,716 |
11,500,719 |
| 14. | Authority for the Company to purchase its own shares*** | 3,871,222,137 |
98.23% |
69,853,695 |
1.77% |
3,941,075,832 |
7,808,603 |
| 15. | Adopt new Articles of Association*** | 3,919,473,970 |
99.55% |
17,602,044 |
0.45% |
3,937,076,014 |
11,808,421 |
Notes:
* Includes discretionary votes.
** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
*** Indicates Special Resolutions requiring a 75% majority.
The following table provides further relevant information:
GlaxoSmithKline's Eighth AGM (2008) |
GlaxoSmithKline's Seventh AGM (2007) |
|
|---|---|---|
| Issued share capital (excluding Treasury Shares) |
5,352,175,102 |
5,725,158,425 |
| Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares) | 73.78% |
73.68% |
| Total shareholder population | 172,581 |
180,486 |
| Total number of proxies lodged | 12,896 |
14,357 |
| % of shareholders who lodged proxies | 7.47% |
7.95% |
| Number of shareholders, corporate representatives and proxies who attended the AGM | 266 |
276 |
S M Bicknell
Company Secretary
21 May 2008
Back to top